Hypoxia Inducible Factors

Supporting information

Hypoxia Inducible Factors (HIFs) are transcription factors that are activated in response to decreased oxygen availability in the cellular environment. They influence cell metabolism, cell survival and angiogenesis to maintain biological homeostasis. The HIF family is made up of α subunits (HIF-1, HIF-2 and HIF-3) and a constitutively expressed β subunit (ARNT; also known as Aryl hydrocarbon Receptor Nuclear Translocator).

The best characterized hypoxia response pathway is mediated by hypoxia-inducible factor-1 (HIF-1). In normoxia (when oxygen is present), prolyl hydroxylases 1-3 (PHD1-3) control the degradation of HIF-1α through hydroxylating several proline residues located at the oxygen-dependent degradation domain of HIF-1α. Hydroxylated HIF-1α interacts with von Hippel-Lindau (VHL) protein targeting it for proteasomal degradation. In hypoxia (the absence of oxygen), the HIFα subunit is stabilized due to the lack of oxygen; it translocates to the nucleus, where it dimerizes with the nuclear HIF-1β (ARNT) to form the transcriptionally active HIF. By interacting with the co-activator CBP/p300, HIF-1 activates transcription of target genes that fall into four major categories: glucose transporters and glycolysis, angiogenesis, survival and proliferation, as well as invasion and metastasis. HIF-2α appears to also be regulated by this mechanism; however, HIF-3α may have a different role in the inhibition of HIF-1α and HIF-2α. HIF thereby regulates gene expression through interaction with specific hypoxic response elements (HRE) on hypoxic responsive genes.

HIF-1α has been shown to play an important role in the tumor response to hypoxia. Hypoxia increases tumor glycolysis, angiogenesis and other survival responses, as well as invasion and metastasis, by activating relevant genes through HIFs. HIF-1α activity in tumors has been correlated with increased angiogenesis and aggressive tumor growth, and therefore has led to current interest in HIF-1α as a pharmacological target within cancer research.

Hypoxia also induces epigenetic changes in chromatin architecture and DNA methylation status, and HIF-1α has also been suggested to regulate several histone demethylase enzymes. View all products for Hypoxia Inducible Factors »

Gene Species Gene Symbol Gene Accession No. Protein Accession No.
Hypoxia Inducible Factor 1, alpha subunit Human HIF1A NM_001530 Q16665 
Mouse Hif1a NM_010431 Q61221
Rat Hif1a NM_024359 O35800
Hypoxia Inducible Factor 1, alpha subunit inhibitor Human HIF1AN NM_017902   Q9NWT6
Mouse Hif1an NM_176958 Q8BLR9
Rat Hif1an NM_001113749 B0BNG5
View all Hypoxia Inducible Factor Gene Data »

Literature for Hypoxia Inducible Factors

Cancer Research Product Guide

A collection of over 750 products for cancer research, the guide includes research tools for the study of:

  • Cancer Metabolism
  • Epigenetics in Cancer
  • Receptor Signaling
  • Cell Cycle and DNA Damage Repair
  • Angiogenesis
  • Invasion and Metastasis
Request copy | Download PDF | View all Product Guides & Listings
Cancer Research Product Guide
Angiogenesis in Cancer Life Science Poster

Angiogenesis is the generation of new blood vessels from pre-existing vasculature. It is a hallmark of cancer and plays a key role in enabling tumor growth, progression and metastasis. Adapted from the 2015 Cancer Product Guide, Edition 3, this poster discusses differences between normal angiogenesis physiology, and tumor vascularization, and highlights therapeutic targets aimed at suppressing angiogenesis.

Request copy | Download PDF | View all posters
Angiogenesis in Cancer Life Science Poster

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Product Guide

Cancer Research Product Guide

Our Cancer Research Guide highlights over 750 products for cancer research. Request copy or view PDF today.

divider line

Angiogenesis in Cancer

Taken from the Cancer Guide Edition 3

Angiogenesis in Cancer Life Science Poster

Our Angiogenesis in Cancer poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets. Request copy or view PDF today.

divider line

Bio-Techne Events

NeuroFrance 2017

NeuroFrance 2017

May 17 - 19, 2017

Bordeaux, France

Booth: 39